Hotwire the Cure: Turning Cold Tumors Hot
Research by Dr. Julyanne Brassard, recently published in Frontiers in Oncology, highlights a promising new therapeutic target for ovarian cancer.
Pain Amplified: Revealing the High Levels of Chronic Pain Among Women Living with HIV
A recent publication by members of the Côté Lab, explores articles published in the last 40 years that investigated pain in WLWH.
CD248 Promotes Insulin Resistance by Binding to the Insulin Receptor and Dampening Its Insulin-Induced Autophosphorylation
Science in Vancouver profiled a recent publication in EBioMedicine from the laboratory of Dr. Edward Conway.
The Clinical Implications of the Connection between COVID-19 and Sepsis
Two recent studies by the Hancock Lab1,2, focus on severe COVID-19 and another infectious disease called sepsis.
How superbugs get their superpowers
A recent study led by UBC researchers in the Strynadka lab is shedding light on how one of the world’s most notorious superbugs, Staphylococcus aureus (S. aureus), develops resistance to antibiotics.
Lipid Nanoparticle Freight Comparison
The Kastrup group compared the effects of two ionizable cations lipids for RNA therapies targeting the liver
Jefferies Lab publication “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”
Publication from Dr. Jefferies Lab: “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”Published: May 15, 2023 https://doi.org/10.3389/fphar.2023.1119607
Jefferies Lab publication “The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain”
Publication from Dr. Jefferies Lab: The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain.Published: April 20, 2023 https://www.nature.com/articles/s41598-023-30054-8
Jefferies Lab publication “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”
Publication from Dr. Jefferies Lab: “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”Published: Feb 22, 2023 https://doi.org/10.3389/fimmu.2022.982082
Innovative treatment targets blood clots without increased bleeding risk
The development of MPI 8 represents a major breakthrough in the field of blood clot prevention and treatment, said Dr. Jayachandran Kizhakkedathu.